Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis PAGE 31 (2023) Abstr 10456 Barceló C, Tanneau L, Acharya C, Ribbing J, Zecchin C, Schalkwijk S. ConferenceInflammationPharmacometricsSpecial considerations Pharmetheus Affiliates Consultant Catalina Barceló See bio Consultant Lénaïg Tanneau See bio Senior Consultant Chayan Acharya See bio Principal Consultant & Client Operations Expert Jakob Ribbing See bio
